Fig. 2From: Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case seriesRhinofibroscopy findings of two patients (A and B) before (T0) and after 12Â months of mepolizumab treatment (T12). Patient A: TENPS was 4 at T0 and 2 at T12 (right nasal cavity. Patient B: TENPS was 3 at T0 and 1 at T12 (left nasal cavity)Back to article page